Login

Ownership

13F as of Q2 2026 · 7.4M shares outstanding

Who owns Kezar Life Sciences, Inc.?

By type of holder
Institutions 0.0% Everyone else 100.0%

No insider has reported a holding in the last two years, so insiders are counted in "Everyone else".

Concentration Top 1 holders own 8.3%
Equal Talent Investments Limited 8.3%
Institutional ownership
0.0%
-60.0 pts vs last qtr
Institutional holders
0
-43 vs last qtr
Net shares bought
−4.4M
by institutions in Q2 2026
New / sold out
0 / 43
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

None.

Biggest sellers in Q2 2026
  • BML Capital Management, LLC SOLD OUT −720.8K
  • Montanova Capital, LLC SOLD OUT −716.8K

Sign up to see all 5.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Kezar Life Sciences, Inc. in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2016–FY2025
+2061.9%
+40.71% a year
Each share's claim on the business
−95.4%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $73M
over 10 fiscal years
Diluted shares, split-adjusted
328.3K3.9M7.4M2016: 338.4K shares'162017: 599.3K shares'172018: 1.0M shares'182019: 1.9M shares'192020: 4.4M shares'202021: 5.3M shares'212022: 6.7M shares'222023: 7.3M shares'232024: 7.3M shares'242025: 7.3M shares'25
Buybacks Stock-based comp
$0$9.1M$18.1M2016 buybacks: $02016 stock comp: $128.0K'162017 buybacks: $02017 stock comp: $203.0K'172018 buybacks: $02018 stock comp: $2.0M'182019 buybacks: $02019 stock comp: $4.0M'192020 buybacks: $02020 stock comp: $4.9M'202021 buybacks: $02021 stock comp: $7.6M'212022 buybacks: $02022 stock comp: $14.0M'222023 buybacks: $02023 stock comp: $18.1M'232024 buybacks: $02024 stock comp: $13.0M'242025 buybacks: $02025 stock comp: $9.0M'25

How patient are the owners?

No 13F manager reports holding Kezar Life Sciences, Inc..

Super Investors

Investment managers reporting Kezar Life Sciences, Inc. on Form 13F
BC
BML Capital Management, LLC
Shares
—
% of company
—
Change vs last qtr
SOLD OUT
Held since
—
MC
Montanova Capital, LLC
Shares
—
% of company
—
Change vs last qtr
SOLD OUT
Held since
—

3 more super investors behind a free account

See every manager holding Kezar Life Sciences, Inc., how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting Kezar Life Sciences, Inc. on Form N-PORT; together they hold 6.1% of the company
VT
Position value
$1.66M
% of company
3.02%
% of the fund
0.00%
As of
March 31, 2026
VE
Position value
$499K
% of company
0.91%
% of the fund
0.00%
As of
March 31, 2026

17 more funds behind a free account

See every fund holding Kezar Life Sciences, Inc. and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
ET
Equal Talent Investments Limited
5%+ holder13D · 8.7%
Shares
616.5K
% of company
8.34%
Change vs last qtr
—
Held since
—

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support